Episodes

  • Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

    Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit
    Apr 27 2025

    Clinical investigators discuss available data guiding the management of biliary tract cancers. 

    CME information and select publications here.
    Show more Show less
    49 mins
  • Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

    Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
    Apr 26 2025

    Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events.

    NCPD information and select publications here.

    Show more Show less
    1 hr and 33 mins
  • Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

    Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
    Apr 23 2025

    Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.

    CME information and select publications here.

    Show more Show less
    53 mins
  • Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

    Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
    Apr 23 2025

    Dr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers.

    CME information and select publications here.
    Show more Show less
    44 mins
  • Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy

    Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy
    Apr 22 2025

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    Show more Show less
    37 mins
  • HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

    HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 21 2025

    Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. 

    CME information and select publications here.
    Show more Show less
    1 hr and 40 mins
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

    Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
    Apr 18 2025

    Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma.

    NCPD information and select publications here.
    Show more Show less
    58 mins
  • Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

    Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
    Apr 17 2025

    Dr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer.

    CME information and select publications here.
    Show more Show less
    1 hr and 30 mins
adbl_web_global_use_to_activate_webcro768_stickypopup